These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34218093)

  • 1. Improving LC/MS/MS-based bioanalytical method performance and sensitivity via a hybrid surface barrier to mitigate analyte - Metal surface interactions.
    Tanna N; Mullin LG; Rainville PD; Wilson ID; Plumb RS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122825. PubMed ID: 34218093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid organic/inorganic hybrid surface technology for increasing the performance of LC/MS(MS)-based drug metabolite identification studies: Application to gefitinib and metabolites in mouse plasma and urine.
    Plumb RS; Gethings LA; King A; Mullin LG; Maker G; Trengove R; Wilson ID
    J Pharm Biomed Anal; 2021 Jun; 200():114076. PubMed ID: 33892395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of hybrid surface technology for the analysis of the B-group vitamins by LC-ESI-MS/MS.
    Yang J; Wilson I; Rainville P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jul; 1204():123336. PubMed ID: 35709669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in high-sensitivity hybrid LC-MS/MS methods for the bioanalysis of protein drugs and performance tests for their validation.
    Duggan JX
    Bioanalysis; 2018 Jul; 10(13):983-986. PubMed ID: 29993264
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of conventional liquid chromatography-tandem mass spectrometry versus microflow liquid chromatography-tandem mass spectrometry within the framework of full method validation for simultaneous quantification of 40 antidepressants and neuroleptics in whole blood.
    Steuer AE; Poetzsch M; Koenig M; Tingelhoff E; Staeheli SN; Roemmelt AT; Kraemer T
    J Chromatogr A; 2015 Feb; 1381():87-100. PubMed ID: 25596763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of microflow LC-MS/MS and its utility in quantitative discovery bioanalysis.
    Zhang J; Shou W; Ogura T; Li S; Weller H
    Bioanalysis; 2019 Jun; 11(11):1117-1127. PubMed ID: 31251100
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative determination of peptide drug in human plasma samples at low pg/ml levels using coupled column liquid chromatography-tandem mass spectrometry.
    Lövgren U; Johansson S; Jensen LS; Ekström C; Carlshaf A
    J Pharm Biomed Anal; 2010 Nov; 53(3):537-45. PubMed ID: 20456896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing test approaches for the detection of exposed metal surfaces within a chromatographic flow path.
    Simeone J; Patel AV; DeLano M; Shiner SJ; Hoyes E; Tracey F; Lauber MA
    J Chromatogr A; 2022 Mar; 1666():462855. PubMed ID: 35144106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and solutions in the bioanalysis of BMS-986094 and its metabolites including a highly polar, active nucleoside triphosphate in plasma and tissues using LC-MS/MS.
    Liu A; Lute J; Gu H; Wang B; Trouba KJ; Arnold ME; Aubry AF; Wang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():29-40. PubMed ID: 26209768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive quantification of purine and pyrimidine metabolism in Alzheimer's disease postmortem cerebrospinal fluid by LC-MS/MS with metal-free column.
    Muguruma Y; Tsutsui H; Akatsu H; Inoue K
    Biomed Chromatogr; 2020 Feb; 34(2):e4722. PubMed ID: 31656052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of in-sample calibration curve methodology for regulated bioanalysis: Critical considerations in method development, validation and sample analysis.
    Yuan L; Gu H; Zeng J; Pillutla RC; Ji QC
    J Pharm Biomed Anal; 2020 Jan; 177():112844. PubMed ID: 31491659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted quantitative bioanalysis in plasma using liquid chromatography/high-resolution accurate mass spectrometry: an evaluation of global selectivity as a function of mass resolving power and extraction window, with comparison of centroid and profile modes.
    Xia YQ; Lau J; Olah T; Jemal M
    Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2863-78. PubMed ID: 21913265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioanalytical method development and validation: Critical concepts and strategies.
    Moein MM; El Beqqali A; Abdel-Rehim M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1043():3-11. PubMed ID: 27720355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How much separation for LC-MS/MS quantitative bioanalysis of drugs and metabolites?
    Tan A; Fanaras JC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():23-35. PubMed ID: 29558737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies.
    Wang SJ; Wu ST; Gokemeijer J; Fura A; Krishna M; Morin P; Chen G; Price K; Wang-Iverson D; Olah T; Weiner R; Tymiak A; Jemal M
    Anal Bioanal Chem; 2012 Jan; 402(3):1229-39. PubMed ID: 22130720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enantioselective quantification of chiral drugs in human plasma with LC-MS/MS.
    Liu K; Zhong D; Chen X
    Bioanalysis; 2009 Jun; 1(3):561-76. PubMed ID: 21083153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples.
    Furlong M; Bessire A; Song W; Huntington C; Groeber E
    Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1902-10. PubMed ID: 20533320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based assay for simultaneous quantification of aldosterone, renin activity, and angiotensin II in human plasma.
    Chen F; Cheng Z; Peng Y; Wang Z; Huang C; Liu D; Wang B; Pan B; Guo W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122740. PubMed ID: 34247101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery, identification and mitigation of isobaric sulfate metabolite interference to a phosphate prodrug in LC-MS/MS bioanalysis: Critical role of method development in ensuring assay quality.
    Yuan L; Ji QC
    J Pharm Biomed Anal; 2018 Jun; 155():141-147. PubMed ID: 29631074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
    de Dios K; Manibusan A; Marsden R; Pinkstaff J
    J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.